Report on how AI is driving market transformation - The global DNA sequencing market size is estimated to grow by USD 17.34 ...

DelveInsight's 'Multiple Sclerosis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline multiple ...

The growing prevalence of cardiovascular and thrombotic disorders is driving strong demand for D-dimer testing. As blood clot-related risk factors continue to increase, the need for precise ...

The T-emerge 2 study was funded by F. Hoffmann-La Roche Ltd. Support for third-party writing assistance for the manuscript, furnished by Giles Brooke and Susan Kaup (UBC-Envision Group ...

The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. Read More on RHHVF: Roche NewsMORE Related Stocks Indices Commodities ...

We explore the history of global pharmaceutical group Hoffmann-La Roche from where it first began, to its core structure and its focus for the future in personalised medicine. Roche was found in ...

Announced an agreement with F. Hoffmann-La Roche Ltd. (Roche) to advance the evaluation of amezalpat in combination with ...

Multiple sclerosis (MS) is a chronic neurological disorder affecting the central nervous system (CNS), particularly the brain, spinal cord, and optic nerves. Continuous research has led to new drug ...

The global cancer tissue diagnostic market is on track for significant growth, with a projected increase from USD 15,302.2 ...

" I’m honored to join Innate Pharma at such a pivotal moment in its evolution,”said Jonathan Dickinson, Chief Executive Officer of Innate Pharma. “ We achieved notable regul ...

The global drug-induced immune hemolytic anemia market, valued at approximately USD 7.8 billion in 2023, is poised for ...